Advances in anticancer radiopharmaceuticals.
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discov...
Главные авторы: | Jackson, MR, Falzone, N, Vallis, K |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2013
|
Схожие документы
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
по: Cornelissen, B, и др.
Опубликовано: (2012) -
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
по: Cornelissen, B, и др.
Опубликовано: (2012) -
Targeted radionuclide therapy: new advances for improvement of patient management and response
по: Malcolm, J, и др.
Опубликовано: (2019) -
Radiopharmaceuticals for imaging and therapy.
по: Faulkner, S, и др.
Опубликовано: (2011) -
Regulation of Radiopharmaceutical Products
по: V. V. Kosenko, и др.
Опубликовано: (2022-12-01)